Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
about
Molecular biology of breast tumors and prognosisBreast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving SurgerySociety of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In SituIs the false-positive rate in mammography in North America too high?Population-based screening for cancer: hope and hype.Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.Truth or Spin? Disease Definition in Cancer Screening.Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database AnalysisEarly dissemination seeds metastasis in breast cancer.Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.Has screening mammography become obsolete?Assessing the acceptability and feasibility of encounter decision aids for early stage breast cancer targeted at underserved patients.Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status.DCIS and axillary nodal evaluation: compliance with national guidelines.A Nationwide Cross-Sectional Survey of UK Breast Surgeons' Views on the Management of Ductal Carcinoma In Situ.Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the communityMolecular classification of non-invasive breast lesions for personalised therapy and chemopreventionPatient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trialAnastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.Current controversies in radiotherapy for breast cancer.The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancerEvaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.The importance of surgical margins in breast cancer.Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice.Impact of Detection Method and Accompanying Ductal Carcinoma in Situ on Prognosis of T1a,bN0 Breast Cancer.Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance.Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment.The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
P2860
Q26748546-5356F552-C9F6-4F21-870A-FCDADB03BDEDQ27347760-012CE29C-3BBE-452A-AA45-2DDC7D3526E6Q28069804-1A9810F3-4DBD-4AFE-8418-1661CF6FD8A8Q28075837-3101D275-0902-4F02-B2AA-E24FF25CF08AQ30250289-3117E161-1C88-4FF5-9B5F-68C5A3CA34F3Q30251601-48002B7D-B381-439C-9B86-0F362CBB3437Q30395721-79151446-3323-42B3-8766-4FEB637E6D24Q30401159-9806B06D-279F-4893-9E2E-3656DAA32DB1Q30491311-330AFBB7-FE9D-41EA-A924-91919FB54627Q30837583-54288F6B-2631-41EC-8F9E-3FF473718E43Q33562263-5FB88E12-E566-4798-A021-FB01F347E094Q33617264-9092DB9C-715A-4BA7-B299-6207654C2637Q33816606-5264937D-2BE2-42D9-8333-2BEB4D6A3EF0Q36131718-03CA3BD1-2CD7-4934-93F8-C9B5903D0786Q36169845-9A84F3AE-BCD0-498C-B2C3-67E7DB4E4736Q36200223-269F6A1C-57A8-415A-9030-49488ACA82BAQ36265582-56664EAB-BCDD-4509-9D37-980C6AAB3E9DQ36273345-AB915FDB-0D55-49BF-930C-EE40D075DE3AQ36366864-B3006F10-6ED5-44B1-A452-370DCA3C4CB2Q36619677-69FBEDFE-437D-4D05-AA9D-2A691F3E7A7CQ36685380-E6754603-E9B6-4207-8E82-60757AD92418Q36689309-1C03DC05-35D5-4B06-A5FF-2DF83F09E45CQ36689416-A1952581-85DE-4775-9D20-26F0D30E9D03Q36887123-89C4441D-473F-4722-9501-75413A3B9EACQ36902060-D2C22D6B-B83B-4AA2-8F5E-073AE493B780Q36915217-06E9267A-157C-4DE8-A351-53812DC27B11Q37101470-D5ACCC54-56FC-4803-9602-0E3E4335F232Q37602477-E2D073C1-A1FD-4A3D-9C62-57648A3DA897Q37690088-9C6448CE-3635-4A17-8684-C95FCD12F3D7Q37701617-88AC0993-C174-4DAB-91A8-EAD9AF647B03Q38429498-FA2A98FC-DDD0-49D0-8E28-94C3F2C4763EQ38591049-00E3D05C-EF3D-49B5-B705-64D8380C957BQ38612319-A0861A5F-8BC8-43EE-ACEC-DF640C41D528Q38619005-B06DE399-F52C-4E66-991B-F73769723A88Q38641730-E4300C7A-27DD-42C7-9873-04DE59EBCCB5Q38648122-531CEED2-AE39-484A-A206-E11D1EE5EEE8Q38682307-65EC23B8-D176-497C-9BAF-654F5A1F6299Q38785778-B4BC5552-C88A-4430-BD9D-5AD43B5F16AEQ38805542-F3C69599-5BF6-47DB-B3AF-7F65A0FE637BQ38840215-D46C56EA-B676-441C-81EA-11675E9202F2
P2860
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
@en
type
label
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
@en
prefLabel
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
@en
P2093
P1433
P1476
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
@en
P2093
Javaid Iqbal
Vasily Giannakeas
Victoria Sopik
P304
P356
10.1001/JAMAONCOL.2015.2510
P577
2015-08-20T00:00:00Z